The North America Veterinary Dermatology Drugs Market would witness market growth of 7.4% CAGR during the forecast period (2021-2027).
Currently, over one-fifth of all animal veterinary meetings are related to dermatological issues. Conditions such as allergies, seborrhoeic dermatitis, otitis externa, and surface pyoderma are some of the commonly diagnosed dermatological conditions. The veterinary dermatology market is still demanding massive improvements in the animal dermatology industry and thus, there is a development in innovating new drugs for the veterinary service.
With the development in the safety and efficacy studies, there have been significant developments made for equine lameness and the makers are willing to boost production capabilities and distribution of the drugs, thereby assisting horses around the world. In the last few years, constant developments in equine dermatological drugs are assisting in treating common diseases like fungal infection, skin inflammation, or an infectious bacterium in horses. The demand for veterinary dermatology drugs would be driven by the fact that the prevalence of diseases in horses is very high around the globe.
North America emerged as the dominant region in the overall veterinary dermatology drugs market and is expected to showcase a similar kind of trend during the forecasting period. The growth of the regional market includes the higher adoption rate of companion animals in well-established nations like Canada, US, and higher expenditure on pet care in this region. According to the American Pet Products Association (APPA) data reveals that 68% of US households, or around 86.4 million homes, have a minimum of one pet.
Conversely, the growth of the regional market would further be driven by the massive prevalence of pruritus, alopecia, sores, masses, pustules, scales, eruptions, seborrhea, and draining tracts in companion animals. Moreover, a key driver for the regional market is the surge in technology in veterinary medicine that has expanded the lifespan of veterinary animals.
The US market dominated the North America Oral Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,354.1 million by 2027. The Canada market is experiencing a CAGR of 9.1% during (2021 - 2027). Additionally, The Mexico market would witness a CAGR of 8.1% during (2021 - 2027).
Based on Route of Administration, the market is segmented into Topical, Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail, Hospital Pharmacies and Online. Based on Drug Indication, the market is segmented into Parasitic Infections, Allergic Infections and Other Indications. Based on Animal Type, the market is segmented into Companion Animal and Livestock Animal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Veterinary Dermatology Drugs Market is Estimated to reach $13.6 Billion by 2027, at a CAGR of 8.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Elanco Animal Health, Inc., Zoetis, Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Vetoquinol SA (Soparfin SCA), Virbac, Bioibérica, S.A.U., Bimeda, Inc., and Ceva Santé Animale.
Scope of the Study
Market Segments Covered in the Report:
By Route of Administration
By Distribution Channel
- Retail
- Hospital Pharmacies
- Online
By Drug Indication
- Parasitic Infections
- Allergic Infections
- Other Indications
By Animal Type
- Companion Animal
- Livestock Animal
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Merck Group
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Vetoquinol SA (Soparfin SCA)
- Virbac
- Bioibérica, S.A.U.
- Bimeda, Inc.
- Ceva Santé Animale
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Veterinary Dermatology Drugs Market, by Route of Administration
1.4.2 North America Veterinary Dermatology Drugs Market, by Distribution Channel
1.4.3 North America Veterinary Dermatology Drugs Market, by Drug Indication
1.4.4 North America Veterinary Dermatology Drugs Market, by Animal Type
1.4.5 North America Veterinary Dermatology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Veterinary Dermatology Drugs Market by Route of Administration
3.1 North America Veterinary Dermatology Drugs Market by Country
3.2 North America Injectable Market by Country
3.3 North America Oral Market by Country
Chapter 4. North America Veterinary Dermatology Drugs Market by Distribution Channel
4.1 North America Retail Market by Country
4.2 North America Hospital Pharmacies Market by Country
4.3 North America Online Market by Country
Chapter 5. North America Veterinary Dermatology Drugs Market by Drug Indication
5.1 North America Parasitic Infections Market by Country
5.2 North America Allergic Infections Market by Country
5.3 North America Other Indications Market by Region
Chapter 6. North America Veterinary Dermatology Drugs Market by Animal Type
6.1 North America Companion Animal Market by Country
6.2 North America Livestock Animal Market by Country
Chapter 7. North America Veterinary Dermatology Drugs Market by Region
7.1 US Veterinary Dermatology Drugs Market
7.1.1 US Veterinary Dermatology Drugs Market by Route of Administration
7.1.2 US Veterinary Dermatology Drugs Market by Distribution Channel
7.1.3 US Veterinary Dermatology Drugs Market by Drug Indication
7.1.4 US Veterinary Dermatology Drugs Market by Animal Type
7.2 Canada Veterinary Dermatology Drugs Market
7.2.1 Canada Veterinary Dermatology Drugs Market by Route of Administration
7.3 Canada Veterinary Dermatology Drugs Market by Distribution Channel
7.4 Canada Veterinary Dermatology Drugs Market by Drug Indication
7.4.1 Canada Veterinary Dermatology Drugs Market by Animal Type
7.5 Mexico Veterinary Dermatology Drugs Market
7.5.1 Mexico Veterinary Dermatology Drugs Market by Route of Administration
7.5.2 Mexico Veterinary Dermatology Drugs Market by Distribution Channel
7.5.3 Mexico Veterinary Dermatology Drugs Market by Drug Indication
7.5.4 Mexico Veterinary Dermatology Drugs Market by Animal Type
7.6 Rest of North America Veterinary Dermatology Drugs Market
7.6.1 Rest of North America Veterinary Dermatology Drugs Market by Route of Administration
7.6.2 Rest of North America Veterinary Dermatology Drugs Market by Distribution Channel
7.6.3 Rest of North America Veterinary Dermatology Drugs Market by Drug Indication
7.6.4 Rest of North America Veterinary Dermatology Drugs Market by Animal Type
Chapter 8. Company Profiles
8.1 Merck Group
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.2 Elanco Animal Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.5.2 Product Launches and product Expansions:
8.3 Zoetis, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trials:
8.4 Eli Lilly and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisitions and Mergers:
8.5 Boehringer Ingelheim International Gmbh
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.6 Vetoquinol SA (Soparfin SCA)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.6.3.2 Acquisitions and Mergers:
8.7 Virbac
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.8 Bioibérica, S.A.U.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Bimeda, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisitions and Mergers:
8.9.2.2 Product Launches and Product Expansions:
8.10. Ceva Santé Animale
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 North America Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 2 North America Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 3 North America Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 4 North America Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 5 North America Veterinary Dermatology Drugs Market by Country, 2017 - 2020, USD Million
TABLE 6 North America Veterinary Dermatology Drugs Market by Country, 2021 - 2027, USD Million
TABLE 7 North America Injectable Market by Country, 2017 - 2020, USD Million
TABLE 8 North America Injectable Market by Country, 2021 - 2027, USD Million
TABLE 9 North America Oral Market by Country, 2017 - 2020, USD Million
TABLE 10 North America Oral Market by Country, 2021 - 2027, USD Million
TABLE 11 North America Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 12 North America Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 13 North America Retail Market by Country, 2017 - 2020, USD Million
TABLE 14 North America Retail Market by Country, 2021 - 2027, USD Million
TABLE 15 North America Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 16 North America Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 17 North America Online Market by Country, 2017 - 2020, USD Million
TABLE 18 North America Online Market by Country, 2021 - 2027, USD Million
TABLE 19 North America Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 20 North America Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 21 North America Parasitic Infections Market by Region, 2017 - 2020, USD Million
TABLE 22 North America Parasitic Infections Market by Region, 2021 - 2027, USD Million
TABLE 23 North America Allergic Infections Market by Country, 2017 - 2020, USD Million
TABLE 24 North America Allergic Infections Market by Country, 2021 - 2027, USD Million
TABLE 25 North America Other Indications Market by Region, 2017 - 2020, USD Million
TABLE 26 North America Other Indications Market by Region, 2021 - 2027, USD Million
TABLE 27 North America Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 28 North America Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 29 North America Companion Animal Market by Country, 2017 - 2020, USD Million
TABLE 30 North America Companion Animal Market by Country, 2021 - 2027, USD Million
TABLE 31 North America Livestock Animal Market by Country, 2017 - 2020, USD Million
TABLE 32 North America Livestock Animal Market by Country, 2021 - 2027, USD Million
TABLE 33 North America Veterinary Dermatology Drugs Market by Region, 2017 - 2020, USD Million
TABLE 34 North America Veterinary Dermatology Drugs Market by Region, 2021 - 2027, USD Million
TABLE 35 US Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 36 US Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 37 US Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 38 US Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 39 US Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 40 US Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 41 US Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 42 US Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 43 US Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 44 US Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 45 Canada Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 46 Canada Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 47 Canada Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 48 Canada Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 49 Canada Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 50 Canada Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 51 Canada Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 52 Canada Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 53 Canada Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 54 Canada Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 55 Mexico Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 56 Mexico Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 57 Mexico Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 58 Mexico Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 59 Mexico Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 60 Mexico Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 61 Mexico Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 62 Mexico Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 63 Mexico Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 64 Mexico Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 65 Rest of North America Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 66 Rest of North America Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 67 Rest of North America Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 68 Rest of North America Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 69 Rest of North America Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 70 Rest of North America Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 71 Rest of North America Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 72 Rest of North America Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 73 Rest of North America Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 74 Rest of North America Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 75 key Information – Merck Group
TABLE 76 Key information – Elanco Animal Health, Inc.
TABLE 77 Key Information – Zoetis, Inc.
TABLE 78 Key Information – Eli Lilly and Company
TABLE 79 Key Information – Boehringer Ingelheim International GmbH
TABLE 80 Key Information – Vetoquinol SA
TABLE 81 Key Information – Virbac
TABLE 82 Key Information – Bioibérica, S.A.U.
TABLE 83 Key Information – Bimeda, Inc.
TABLE 84 Key Information – Ceva Santé Animale
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Bioibérica, S.A.U.
FIG 3 Recent strategies and developments: Bimeda, Inc.